The world is in a race to develop vaccines against the novel coronavirus SARS-CoV-2 and the disease it causes, COVID-19. We are determined to defeat this disease, which continues to infect millions of people and cause death and suffering around the world. Given the urgent crisis, it’s clear that a vaccine cannot be developed soon…
On February 26th, 2020, Latin Americans ceased to be coronavirus spectators and began enduring its effects in their own flesh. Since then, a fragile and unprepared healthcare system for a pandemic has been exposed. As a result, initiatives such as telemedicine have gained strength and have been positioned as an alternative to traditional medicine. Telemedicine…
On May 20th, the International Clinical Trials Day was celebrated. It was on January 1922 when Leonard Thompson, a 14-year-old diabetic who was about to die at Toronto General Hospital, was the first receiving insulin, discovered by scientists Frederick Grant Banting and Charles Herber Best. Day by day, after administering the medicine, the miraculous recovery…
On March 25, 2020, a consortium of life science companies with the Bill & Melinda Gates Foundation announced a collaboration to promote the development, manufacture, and delivery of diagnostics and treatments to combat COVID-19. With extensive years of expertise in the healthcare sector and the pharmaceutical research, these expert companies will raise financial aid and…
Johnson & Johnson announces an important finding in the fight against COVID-19! As a result of its efforts in pharmaceutical research and innovation, this company announced that it will begin the phase of human clinical studies at the latest by September 2020. This good news would mean an achievement in vaccine development, compared to the…
The Coronavirus outbreak (2019-nCoV) was declared a pandemic by the Director-General of the World Health Organization (WHO), responding to the rapid spread of this pathology. This statement shows the dangerous nature of the virus, and the need to find effective treatments and strengthen available healthcare systems, especially in Latin America, which has already started reporting…
On January 21st, FIFARMA organized the Webinar entitled: APEC: Opportunities for Latam. This virtual talk discussed the opportunities in Latin America in regulatory training issues, especially in recent years. Our Executive Director Rafael Andrés Díaz-Granados moderated and opened this talk. APEC unveiled convergence and regulatory training opportunities for the region. The steering committee for harmonization…
The International Federation of Manufacturers and Associations of Pharmaceutical Products (IFPMA) recently published two reports that contribute to research, development, implementation and dissemination of information on vaccines and immunization -essential topics in the improvement of global health. One of them is The complex journey of a vaccine, a report dealing with the process of developing…
The ISPOR Latin American Conference was held in Bogotá, Colombia, between September 12th and 14th, 2019. This biannual meeting is the largest event in the health sector in Latin America! Over 1,100 attendees from nearly 34 countries met to discuss how to improve the decision-making process for increasing access to new healthcare technologies and how…
